320 related articles for article (PubMed ID: 28853212)
1. Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.
Anugraham M; Jacob F; Everest-Dass AV; Schoetzau A; Nixdorf S; Hacker NF; Fink D; Heinzelmann-Schwarz V; Packer NH
Mol Oncol; 2017 Nov; 11(11):1595-1615. PubMed ID: 28853212
[TBL] [Abstract][Full Text] [Related]
2. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
[TBL] [Abstract][Full Text] [Related]
3. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
5. A platform for the structural characterization of glycans enzymatically released from glycosphingolipids extracted from tissue and cells.
Anugraham M; Everest-Dass AV; Jacob F; Packer NH
Rapid Commun Mass Spectrom; 2015 Apr; 29(7):545-61. PubMed ID: 26212272
[TBL] [Abstract][Full Text] [Related]
6. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype.
Madunić K; Zhang T; Mayboroda OA; Holst S; Stavenhagen K; Jin C; Karlsson NG; Lageveen-Kammeijer GSM; Wuhrer M
Cell Mol Life Sci; 2021 Jan; 78(1):337-350. PubMed ID: 32236654
[TBL] [Abstract][Full Text] [Related]
8. Resolving Isomeric Structures of Native Glycans by Nanoflow Porous Graphitized Carbon Chromatography-Mass Spectrometry.
She YM; Tam RY; Li X; Rosu-Myles M; Sauvé S
Anal Chem; 2020 Oct; 92(20):14038-14046. PubMed ID: 32960038
[TBL] [Abstract][Full Text] [Related]
9. Standardization of PGC-LC-MS-based glycomics for sample specific glycotyping.
Ashwood C; Pratt B; MacLean BX; Gundry RL; Packer NH
Analyst; 2019 Jun; 144(11):3601-3612. PubMed ID: 31065629
[TBL] [Abstract][Full Text] [Related]
10. High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer.
Jacob F; Marchetti RL; Kind AB; Russell K; Schoetzau A; Heinzelmann-Schwarz VA
Mol Oncol; 2021 Jan; 15(1):91-103. PubMed ID: 33016563
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive glycome profiling of Huntington's disease transgenic mice.
Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S
Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331
[TBL] [Abstract][Full Text] [Related]
12. Mucins and Truncated
Coelho R; Marcos-Silva L; Mendes N; Pereira D; Brito C; Jacob F; Steentoft C; Mandel U; Clausen H; David L; Ricardo S
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011875
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of Isomers of Released N- and O-Glycans Using Diagnostic Product Ions in Negative Ion PGC-LC-ESI-MS/MS.
Ashwood C; Lin CH; Thaysen-Andersen M; Packer NH
J Am Soc Mass Spectrom; 2018 Jun; 29(6):1194-1209. PubMed ID: 29603058
[TBL] [Abstract][Full Text] [Related]
14. Deep Structural Analysis and Quantitation of O-Linked Glycans on Cell Membrane Reveal High Abundances and Distinct Glycomic Profiles Associated with Cell Type and Stages of Differentiation.
Xu G; Goonatilleke E; Wongkham S; Lebrilla CB
Anal Chem; 2020 Mar; 92(5):3758-3768. PubMed ID: 32039582
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
[TBL] [Abstract][Full Text] [Related]
16. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease.
Kupryjanczyk J; Thor AD; Beauchamp R; Poremba C; Scully RE; Yandell DW
Mod Pathol; 1996 Mar; 9(3):166-73. PubMed ID: 8685209
[TBL] [Abstract][Full Text] [Related]
17. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
[TBL] [Abstract][Full Text] [Related]
18. Post-Column Make-Up Flow (PCMF) Enhances the Performance of Capillary-Flow PGC-LC-MS/MS-Based Glycomics.
Hinneburg H; Chatterjee S; Schirmeister F; Nguyen-Khuong T; Packer NH; Rapp E; Thaysen-Andersen M
Anal Chem; 2019 Apr; 91(7):4559-4567. PubMed ID: 30810297
[TBL] [Abstract][Full Text] [Related]
19. Fast and efficient online release of N-glycans from glycoproteins facilitating liquid chromatography-tandem mass spectrometry glycomic profiling.
Jmeian Y; Hammad LA; Mechref Y
Anal Chem; 2012 Oct; 84(20):8790-6. PubMed ID: 22978794
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome.
Auer K; Bachmayr-Heyda A; Aust S; Sukhbaatar N; Reiner AT; Grimm C; Horvat R; Zeillinger R; Pils D
Oncotarget; 2015 Jul; 6(19):17261-75. PubMed ID: 25991672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
